bpc 157 peptide thorne BPC-157 Specification:20 mg no-glp1 AOD-9604 was developed from

bpc 157 peptide thorne BPC-157 Specification:20 mg no-glp1 AOD-9604 was developed from

AOD-9604 was developed from a fragment of human growth hormone because preclinical research suggested effects on fat metabolism. The human evidence did not confirm a consistent, clinically meaningful weight-loss benefit. Development was

Under the designation PL-14736 it did enter clinical investigation for inflammatory bowel disease, which is noted in Klicek and colleagues' 2008 paper on colocutaneous fistula healing in rats — but entering trials is not the same as completing them, and no controlled human efficacy results have been published

no-glp1

Specification:20 mg

Systematic Reviews 2014;3:82